Elevated Kallistatin Promotes the Occurrence and Progression of Non-Alcoholic Fatty Liver Disease

Scientists illuminated the causative contributor and potential mechanism of Kallistatin mediating HLP to NAFLD. 221 healthy control and 253 HLP subjects, 62 healthy control and 44 non-alcoholic fatty liver disease subjects were enrolled.